Daisuke Yamabe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daisuke Yamabe has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Akihiko Hiyama
Department of Orthopaedic Surgery, Tokai University School of Medicine, Kanagawa, Japan
3 shared publications - Atsushi Kimura
Department of Orthopaedics, Jichi Medical University, Shimotsuke, Japan
3 shared publications - Bungo Otsuki
Department of Orthopaedic Surgery, Kyoto University, Graduate School of Medicine, Kyoto, Japan
3 shared publications - Chizuo Iwai
Department of Orthopaedic Surgery, Gifu University Hospital, Gifu, Japan
3 shared publications - Eiki Shirasawa
Department of Orthopaedic Surgery, Kitasato University School of Medicine, Sagamihara 252-0374, Kanagawa, Japan
3 shared publications - Gen Inoue
Department of Orthopaedic Surgery, Kitasato University School of Medicine, 1-15-1 Minami-ku, Kitasato, Sagamihara 252-0374, Kanagawa, Japan
3 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Outcome Analysis in Metastatic Spinal Tumor Surgery Using Minimal Clinically Important Difference
Study Design: Multicenter prospective registry study. Objective: To classify patients according to whether they achieved the minimum clinically important difference (MCID) in health-related quality of life (HRQoL) after surgery for metastatic spinal tumors and to identify preoperative factors associated with clinically meaningful improvement. Summary of Background Data: As survival in patients with metastatic spinal tumors continues to improve, evaluating clinically meaningful changes in HRQoL has become increasingly important. However, factors associated with achieving clinically meaningful postoperative improvement remain unclear. Methods: Between 2018 and 2021, 413 patients undergoing surgery for metastatic spinal tumors were prospectively enrolled from 35 centers in Japan. Patients with available preoperative and 6-month postoperative EQ-5D-5L data were included in the MCID analysis (n=171). Patients were classified into the MCID improvement and non-MCID improvement groups according to the previously established MCID threshold for the EQ-5D-5L index. Patient-reported outcomes (PROs), clinical characteristics, and functional measures were compared between groups, and multivariable logistic regression analysis was performed to identify preoperative factors associated with clinically meaningful improvement. Results: Patients in the MCID improvement group demonstrated significantly greater improvements in the EQ-5D-5L index, EQ-VAS, and other PRO measures than those in the non-MCID improvement group. Compared with the non-MCID improvement group, they had poorer baseline HRQoL, poorer functional status, greater pain, and lower independence in activities of daily living. Exploratory multivariable analysis identified lower independence in dressing and greater impairment in the mobility, pain/discomfort, and anxiety/depression domains as candidate factors associated with clinically meaningful improvement. Conclusion: Patients with poorer baseline HRQoL and functional status were more likely to achieve clinically meaningful improvement after surgery for metastatic spinal tumors. These findings suggest that baseline HRQoL should be considered when interpreting postoperative outcomes and counseling patients regarding the expected benefits of surgical treatment.
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Open AccessOutcome Analysis in Metastatic Spinal Tumor Surgery Using Minimal Clinically Important Difference
Study Design: Multicenter prospective registry study. Objective: To classify patients according to whether they achieved the minimum clinically important difference (MCID) in health-related quality of life (HRQoL) after surgery for metastatic spinal tumors and to identify preoperative factors associated with clinically meaningful improvement. Summary of Background Data: As survival in patients with metastatic spinal tumors continues to improve, evaluating clinically meaningful changes in HRQoL has become increasingly important. However, factors associated with achieving clinically meaningful postoperative improvement remain unclear. Methods: Between 2018 and 2021, 413 patients undergoing surgery for metastatic spinal tumors were prospectively enrolled from 35 centers in Japan. Patients with available preoperative and 6-month postoperative EQ-5D-5L data were included in the MCID analysis (n=171). Patients were classified into the MCID improvement and non-MCID improvement groups according to the previously established MCID threshold for the EQ-5D-5L index. Patient-reported outcomes (PROs), clinical characteristics, and functional measures were compared between groups, and multivariable logistic regression analysis was performed to identify preoperative factors associated with clinically meaningful improvement. Results: Patients in the MCID improvement group demonstrated significantly greater improvements in the EQ-5D-5L index, EQ-VAS, and other PRO measures than those in the non-MCID improvement group. Compared with the non-MCID improvement group, they had poorer baseline HRQoL, poorer functional status, greater pain, and lower independence in activities of daily living. Exploratory multivariable analysis identified lower independence in dressing and greater impairment in the mobility, pain/discomfort, and anxiety/depression domains as candidate factors associated with clinically meaningful improvement. Conclusion: Patients with poorer baseline HRQoL and functional status were more likely to achieve clinically meaningful improvement after surgery for metastatic spinal tumors. These findings suggest that baseline HRQoL should be considered when interpreting postoperative outcomes and counseling patients regarding the expected benefits of surgical treatment.
- 26 August 2026
- Published by Wolters Kluwer Health in Spine
Deep Learning Versus LASSO-Based Machine Learning for 1-Year Survival After Surgery for Spinal Metastases
Study Design.: Multicenter prospective cohort study; secondary analysis. Objective.: To evaluate predictors associated with 1-year survival after surgery for spinal metastases by comparing a comprehensive 50-variable deep learning (DL) model with a previously published 5-variable LASSO-based machine learning (ML) model and applying DL-based permutation feature importance as an exploratory analytic lens. Summary of Background Data.: Surgical decision-making for spinal metastases requires reliable survival estimates. Traditional scores such as those of Tokuhashi and Tomita and contemporary tools such as SORG and NESMS support prognostication, but performance and calibration may vary across cohorts. A parsimonious 5-variable JASA ML model is clinically practical, whereas DL may help identify prognostic signals embedded in detailed activities of daily living (ADLs), patient-reported outcomes (PROs), and scoring-system components. Methods.: We analyzed 401 complete-case patients who underwent surgery for spinal metastases at 35 Japanese institutions (2018-2021). A feed-forward neural network incorporating 50 preoperative variables was evaluated using five repeated random 8:2 train-test splits. Accuracy, AUROC, Brier score, and calibration summaries were reported and descriptively compared with the previously published 5-variable LASSO-based ML model. Results.: At 1 year, 269 of 401 patients were alive. The DL model achieved 75.5+/- 3.0% accuracy (95% confidence interval [CI], 71.8%-79.2%), held-out AUROC 0.789 (95% CI, 0.681-0.886), and Brier score 0.214. The ML model achieved 71.8% accuracy (Wilson 95% CI, 67.2%-76.0%) and apparent AUROC 0.762. Because the comparison was descriptive rather than paired, formal statistical superiority was not claimed. DL feature importance highlighted Vitality Index-On and Off Toilet, EQ-5D-5L total score and pain/discomfort, and individual Tokuhashi/Tomita components; the ML-selected Vitality Index-Wake Up item ranked 38th. Conclusions.: The 50-variable DL model provided reasonable prediction and generated clinically plausible feature-importance hypotheses, but it did not demonstrate a clearly meaningful performance advantage over the simpler 5-variable ML model. DL may be most useful for research-based feature discovery and refinement of future parsimonious prognostic tools, whereas validated simple models remain more practical for bedside prognostication. Level of Evidence.: 2
- 26 August 2026
- Published by Wolters Kluwer Health in Spine
Deep Learning Versus LASSO-Based Machine Learning for 1-Year Survival After Surgery for Spinal Metastases
Study Design.: Multicenter prospective cohort study; secondary analysis. Objective.: To evaluate predictors associated with 1-year survival after surgery for spinal metastases by comparing a comprehensive 50-variable deep learning (DL) model with a previously published 5-variable LASSO-based machine learning (ML) model and applying DL-based permutation feature importance as an exploratory analytic lens. Summary of Background Data.: Surgical decision-making for spinal metastases requires reliable survival estimates. Traditional scores such as those of Tokuhashi and Tomita and contemporary tools such as SORG and NESMS support prognostication, but performance and calibration may vary across cohorts. A parsimonious 5-variable JASA ML model is clinically practical, whereas DL may help identify prognostic signals embedded in detailed activities of daily living (ADLs), patient-reported outcomes (PROs), and scoring-system components. Methods.: We analyzed 401 complete-case patients who underwent surgery for spinal metastases at 35 Japanese institutions (2018-2021). A feed-forward neural network incorporating 50 preoperative variables was evaluated using five repeated random 8:2 train-test splits. Accuracy, AUROC, Brier score, and calibration summaries were reported and descriptively compared with the previously published 5-variable LASSO-based ML model. Results.: At 1 year, 269 of 401 patients were alive. The DL model achieved 75.5+/- 3.0% accuracy (95% confidence interval [CI], 71.8%-79.2%), held-out AUROC 0.789 (95% CI, 0.681-0.886), and Brier score 0.214. The ML model achieved 71.8% accuracy (Wilson 95% CI, 67.2%-76.0%) and apparent AUROC 0.762. Because the comparison was descriptive rather than paired, formal statistical superiority was not claimed. DL feature importance highlighted Vitality Index-On and Off Toilet, EQ-5D-5L total score and pain/discomfort, and individual Tokuhashi/Tomita components; the ML-selected Vitality Index-Wake Up item ranked 38th. Conclusions.: The 50-variable DL model provided reasonable prediction and generated clinically plausible feature-importance hypotheses, but it did not demonstrate a clearly meaningful performance advantage over the simpler 5-variable ML model. DL may be most useful for research-based feature discovery and refinement of future parsimonious prognostic tools, whereas validated simple models remain more practical for bedside prognostication. Level of Evidence.: 2
- 10 July 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (19) , E510-E512
Response to the Letter to the Editor Regarding “Predicting Postoperative Neurological Outcomes in Metastatic Spinal Tumor Surgery Using Machine Learning”
Was not provided for this article.
- 10 July 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (19) , E510-E512
Response to the Letter to the Editor Regarding “Predicting Postoperative Neurological Outcomes in Metastatic Spinal Tumor Surgery Using Machine Learning”
Was not provided for this article.
- Open Access
- 22 January 2025
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2025 (1) , 9514578
Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu)
Background: Familial hypocalciuric hypercalcemia type 3 (FHH3) is a rare hereditary disorder caused by a heterozygous AP2S1 gene mutation, characterized by hypocalciuria and hypercalcemia due to impaired intracellular signal transduction of calcium (Ca)‐sensing receptors (CaSRs). All affected patients harbored a heterozygous missense mutation at the Arg15 residue of the encoded AP2σ1. Case Presentation: A 21‐year‐old female was referred to our hospital with hypercalcemia and reduced bone mineral density (BMD) detected during a preoperative examination for scoliosis surgery. She had a developmental disorder and exhibited hypocalciuria on urinalysis. Genetic testing revealed a heterozygous AP2S1 gene mutation (p.Arg15Leu), and the patient was diagnosed with FHH3. In the present case, we investigated the effects of evocalcet, a newly approved CaSR agonist. Treatment with evocalcet gradually decreased and normalized the serum Ca level, and promoted improvements in bone metabolism, without serious adverse events. Conclusion: Evocalcet may be a promising therapeutic candidate for symptomatic FHH3.
- 22 January 2025
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2025 (1) , 9514578
Open AccessSuccessful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu)
Background: Familial hypocalciuric hypercalcemia type 3 (FHH3) is a rare hereditary disorder caused by a heterozygous AP2S1 gene mutation, characterized by hypocalciuria and hypercalcemia due to impaired intracellular signal transduction of calcium (Ca)‐sensing receptors (CaSRs). All affected patients harbored a heterozygous missense mutation at the Arg15 residue of the encoded AP2σ1. Case Presentation: A 21‐year‐old female was referred to our hospital with hypercalcemia and reduced bone mineral density (BMD) detected during a preoperative examination for scoliosis surgery. She had a developmental disorder and exhibited hypocalciuria on urinalysis. Genetic testing revealed a heterozygous AP2S1 gene mutation (p.Arg15Leu), and the patient was diagnosed with FHH3. In the present case, we investigated the effects of evocalcet, a newly approved CaSR agonist. Treatment with evocalcet gradually decreased and normalized the serum Ca level, and promoted improvements in bone metabolism, without serious adverse events. Conclusion: Evocalcet may be a promising therapeutic candidate for symptomatic FHH3.
- Open Access
- 20 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e835-e843
Comparison of the Susceptibility to Implant Failure in the Lateral, Posterior, and Transforaminal Lumbar Interbody Fusion: A Finite Element Analysis
- 20 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e835-e843
Open AccessComparison of the Susceptibility to Implant Failure in the Lateral, Posterior, and Transforaminal Lumbar Interbody Fusion: A Finite Element Analysis
- Open Access
- 16 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (4) , 1020
Comparison of Hybrid Posterior Fixation and Conventional Open Posterior Fixation Combined with Multilevel Lateral Lumbar Interbody Fusion for Adult Spinal Deformity
We compared radiological and clinical outcomes between multilevel lateral lumbar interbody fusion (LLIF) + hybrid posterior fixation (PF) and multilevel LLIF + conventional open PF in patients with adult spinal deformity (ASD). Patients who underwent minimally invasive surgery for ASD in a single institution between 2014 and 2018 were retrospectively reviewed. Fifty-six patients (hybrid PF, 30; open PF, 26) who underwent ASD correction surgery were enrolled between 2014 and 2018. We evaluated patients’ demographics, clinical outcomes, and radiographical parameters in each group. There was significantly less estimated blood loss in the hybrid PF group (662.8 mL vs. 1088.8 mL; p = 0.012). The CRP level 7 days after surgery was significantly lower in the hybrid PF group (2.9 mg/dL vs. 4.3 mg/dL; p = 0.035). There was no significant difference between the two groups in other demographic variables, visual analog scores for back pain and leg pain, Oswestry Disability Index, coronal Cobb angle, lumbar lordosis, pelvic tilt, pelvic incidence–lumbar lordosis mismatch, and sagittal vertical axis. There was a significantly higher percentage of major complications in the open PF group (42.3% vs. 13.3%; p = 0.039). Thus, LLIF + hybrid PF for ASD corrective surgery may be comparable to LLIF + open PF in terms of clinical and radiographic outcomes.
- 16 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (4) , 1020
Open AccessComparison of Hybrid Posterior Fixation and Conventional Open Posterior Fixation Combined with Multilevel Lateral Lumbar Interbody Fusion for Adult Spinal Deformity
We compared radiological and clinical outcomes between multilevel lateral lumbar interbody fusion (LLIF) + hybrid posterior fixation (PF) and multilevel LLIF + conventional open PF in patients with adult spinal deformity (ASD). Patients who underwent minimally invasive surgery for ASD in a single institution between 2014 and 2018 were retrospectively reviewed. Fifty-six patients (hybrid PF, 30; open PF, 26) who underwent ASD correction surgery were enrolled between 2014 and 2018. We evaluated patients’ demographics, clinical outcomes, and radiographical parameters in each group. There was significantly less estimated blood loss in the hybrid PF group (662.8 mL vs. 1088.8 mL; p = 0.012). The CRP level 7 days after surgery was significantly lower in the hybrid PF group (2.9 mg/dL vs. 4.3 mg/dL; p = 0.035). There was no significant difference between the two groups in other demographic variables, visual analog scores for back pain and leg pain, Oswestry Disability Index, coronal Cobb angle, lumbar lordosis, pelvic tilt, pelvic incidence–lumbar lordosis mismatch, and sagittal vertical axis. There was a significantly higher percentage of major complications in the open PF group (42.3% vs. 13.3%; p = 0.039). Thus, LLIF + hybrid PF for ASD corrective surgery may be comparable to LLIF + open PF in terms of clinical and radiographic outcomes.
- Open Access
Quantification of metal‐induced susceptibility artifacts associated with ultrahigh‐field magnetic resonance imaging of spinal implants
Reports on spinal‐implant metallic artifacts in 7‐T magnetic resonance imaging (MRI) are lacking. Thus, we investigated the magnitude of metal artifacts derived from spinal implants in 7‐T MRI and analyzed the differences obtained with spinal rods manufactured from pure titanium, titanium alloy, and cobalt‐chrome (5.5‐mm and 6.0‐mm diameters and 50‐mm length). Following the American Society for Testing and Materials guidelines, we measured the artifact size and artifact volume ratio of each rod during image acquisition using 7‐T MRI scanners with three‐dimensional (3D) T1‐weighted and 3D T2* spoiled gradient echo (GRE), 3D T2‐weighted fast spin echo, zero echo time (ZTE), and diffusion‐weighted imaging sequences. Pure titanium and titanium alloy rods yielded significantly smaller artifacts than did cobalt‐chrome rods, with no significant difference between pure titanium and titanium alloy rods. The artifact sizes of the 5.5‐mm and 6.0‐mm diameter rods were similar. The artifact magnitude increased in the following sequence order: ZTE, 3D T2 fast spin echo, 3D T1 spoiled GRE, 3D T2* spoiled GRE, and diffusion‐weighted imaging. Artifacts obtained using the spin echo method were smaller than those obtained with the GRE method. Because the echo time in ZTE is extremely short, the occurrence of artifacts because of image distortion and signal loss caused by differences in magnetic susceptibility is minimal, resulting in the smallest artifacts. ZTE can be a clinically useful method for the postoperative evaluation of patients after instrumentation surgery, even with 7‐T MRI.
Open AccessQuantification of metal‐induced susceptibility artifacts associated with ultrahigh‐field magnetic resonance imaging of spinal implants
Reports on spinal‐implant metallic artifacts in 7‐T magnetic resonance imaging (MRI) are lacking. Thus, we investigated the magnitude of metal artifacts derived from spinal implants in 7‐T MRI and analyzed the differences obtained with spinal rods manufactured from pure titanium, titanium alloy, and cobalt‐chrome (5.5‐mm and 6.0‐mm diameters and 50‐mm length). Following the American Society for Testing and Materials guidelines, we measured the artifact size and artifact volume ratio of each rod during image acquisition using 7‐T MRI scanners with three‐dimensional (3D) T1‐weighted and 3D T2* spoiled gradient echo (GRE), 3D T2‐weighted fast spin echo, zero echo time (ZTE), and diffusion‐weighted imaging sequences. Pure titanium and titanium alloy rods yielded significantly smaller artifacts than did cobalt‐chrome rods, with no significant difference between pure titanium and titanium alloy rods. The artifact sizes of the 5.5‐mm and 6.0‐mm diameter rods were similar. The artifact magnitude increased in the following sequence order: ZTE, 3D T2 fast spin echo, 3D T1 spoiled GRE, 3D T2* spoiled GRE, and diffusion‐weighted imaging. Artifacts obtained using the spin echo method were smaller than those obtained with the GRE method. Because the echo time in ZTE is extremely short, the occurrence of artifacts because of image distortion and signal loss caused by differences in magnetic susceptibility is minimal, resulting in the smallest artifacts. ZTE can be a clinically useful method for the postoperative evaluation of patients after instrumentation surgery, even with 7‐T MRI.